Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

NCT01044069 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: gene-modified T cells targeted

Sponsor

Memorial Sloan Kettering Cancer Center